Skip to main content
Caplight Logo









Cocoon Bioscience

Cocoon Bioscience

Private
DerioHealthcare & Life Scienceshttps://cocoonbio.com/

Last Round

Series A

Mar 20, 2023

Total Funding Raised

$15.9M

Company Overview

Cocoon Bioscience is a biotechnology company that manufactures recombinant proteins, such as specialty enzymes and growth factors, using insects as natural bioreactors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clean Manufacturing, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

recombinant protein manufacturinginsect bioreactorgrowth factorsspecialty enzymesbiologics CDMOcultivated meat ingredientsbiomanufacturingprotein expression systemBaculovirus Expression Vector SystemBEVSlab-grown meat inputsCrisBio®cellular agriculturesingle-use bioreactorcustom enzyme developmentmRNA therapy components

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cocoon Bioscience Comparables

Compare Cocoon Bioscience with similar companies based on industry and business-model similarity.

Cocoon Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Future Fields
88%
Insud Pharma
79%
Core Biogenesis
78%

Cocoon Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 20, 2023

Key People

Founding team and executive leadership

Romy Moreno Dalton

Chief Operating Officer Directora de Operaciones at Cocoon Bioscience (spin-off Algenex)

Executive Team

Cocoon Bioscience Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 2, 2025

    Grew 16% QoQ, from 37 to 43 employees.

  • May 3, 2025

    Grew 17% QoQ, from 35 to 41 employees.

Cocoon Bioscience Filings

Explore SEC and related filing metadata, where available.

Cocoon Bioscience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cocoon Bioscience's valuation, stock price, and market status.

Is Cocoon Bioscience a public or private company?

Cocoon Bioscience is a private company.

What is the current stock price of Cocoon Bioscience?

Cocoon Bioscience is a private company with no public stock price. No recent secondary market data is available.

How much is Cocoon Bioscience worth (valuation)?

Valuation information for Cocoon Bioscience is not publicly available.

Can I buy Cocoon Bioscience stock?

Cocoon Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cocoon Bioscience's last funding round?

Cocoon Bioscience's most recent funding round was Series A on March 20, 2023.

Who are the main investors in Cocoon Bioscience?

Key investors in Cocoon Bioscience include Cleon Capital, Columbus Venture Partners.

Will Cocoon Bioscience IPO soon?

No public IPO plans have been announced for Cocoon Bioscience.

How can I track Cocoon Bioscience secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cocoon Bioscience's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDerio
Employee Range26
Year Founded2022
Last FundingMar 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?